Urate levels and clearance in renal patients under peritoneal dialysis

References

• Bobulescu, I. A.; Moe, O. W. Renal Transport of Uric Acid: Evolving Concepts and Uncertainties. Adv. Chron. Kidney Dis. 2012, 19, 358–371. DOI: 10.1053/j.ackd.2012.07.009.
   PubMed Web of Science ®Google Scholar
• Ichida, K.; Matsuo, H.; Takada, T.; Nakayama, A.; Murakami, K.; Shimizu, T.; Yamanashi, Y.; Kasuga, H.; Nakashima, H.; Nakamura, T.; et al. Decreased Extra-Renal Urate Excretion is a Common Cause of Hyperuricemia. Nat. Commun. 2012, 3, 764. DOI: 10.1038/ncomms1756.
   PubMed Web of Science ®Google Scholar
• Roughley, M.; Sultan, A. A.; Clarson, L.; Muller, S.; Whittle, R.; Belcher, J.; Mallen, C. D.; Roddy, E. Risk of Chronic Kidney Disease in Patients with Gout and the Impact of Urate Lowering Therapy: A Population-Based Cohort Study. Arthrit. Res. Ther. 2018, 20, 243. DOI: 10.1186/s13075-018-1746-1.
   PubMed Web of Science ®Google Scholar
• Jing, J.; Kielstein, J. T.; Schultheiss, U. T.; Sitter, T.; Titze, S. I.; Schaeffner, E. S.; McAdams-DeMarco, M.; Kronenberg, F.; Eckardt, K.-U.; Köttgen, A. GCKD Study Investigators. Prevalence and Correlates of Gout in a Large Cohort of Patients with Chronic Kidney Disease: The German Chronic Kidney Disease (GCKD) Study. Nephrol. Dial. Transplant 2015, 30, 613–621. DOI: 10.1093/ndt/gfu352.
   PubMed Web of Science ®Google Scholar
• Mazzali, M.; Kanellis, J.; Han, L.; Feng, L.; Xia, Y.-Y.; Chen, Q.; Kang, D.-H.; Gordon, K. L.; Watanabe, S.; Nakagawa, T.; et al. Hyperuricemia Induces a Primary Renal Arteriolopathy in Rats by a Blood Pressure-Independent Mechanism. Am. J. Physiol. Renal. Physiol. 2002, 282, F991–997. DOI: 10.1152/ajprenal.00283.2001.
   PubMed Web of Science ®Google Scholar
• Linnane, J. W.; Burry, A. F.; Emmerson, B. T. Urate Deposits in the Renal Medulla. Prevalence and Associations. Nephron 1981, 29, 216–222. DOI: 10.1159/000182373.
   PubMed Web of Science ®Google Scholar
• Pascual, E.; Sivera, F.; Andrés, M. Managing Gout in the Patient with Renal Impairment. Drugs Aging. 2018, 35, 263–273. DOI: 10.1007/s40266-018-0517-7.
   PubMed Web of Science ®Google Scholar
• Slinin, Y.; Greer, N.; Ishani, A.; MacDonald, R.; Olson, C.; Rutks, I.; Wilt, T. J. Timing of Dialysis Initiation, Duration and Frequency of Hemodialysis Sessions, and Membrane Flux: A Systematic Review for a KDOQI Clinical Practice Guideline. Am. J. Kidney Dis. 2015, 66, 823–836. DOI: 10.1053/j.ajkd.2014.11.031.
   PubMed Web of Science ®Google Scholar
• Goldberg, M.; Castleman, L.; Wallace, S. L. Removal of Uric Acid by the Artificial Kidney in Patients with Acute Renal Failure. J. Lab. Clin. Med. 1960, 55, 268–273.
   PubMed Web of Science ®Google Scholar
• Dalbeth, N.; Stamp, L. Allopurinol Dosing in Renal Impairment: Walking the Tightrope between Adequate Urate Lowering and Adverse Events. Semin. Dial. 2007, 20, 391–395. DOI: 10.1111/j.1525-139X.2007.00270.x.
   PubMed Web of Science ®Google Scholar
• Dong, J.; Han, Q.-F.; Zhu, T.-Y.; Ren, Y.-P.; Chen, J.-H.; Zhao, H.-P.; Chen, M.-H.; Xu, R.; Wang, Y.; Hao, C.-M.; et al. The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients. PLoS One. 2014, 9, e82342. DOI: 10.1371/journal.pone.0082342.
   PubMed Web of Science ®Google Scholar
• Park, J. T.; Kim, D. K.; Chang, T. I.; Kim, H. W.; Chang, J. H.; Park, S. Y.; Kim, E.; Kang, S.-W.; Han, D.-S.; Yoo, T.-H. Uric Acid is Associated with the Rate of Residual Renal Function Decline in Peritoneal Dialysis Patients. Nephrol. Dial. Transpl. 2009, 24, 3520–3525. DOI: 10.1093/ndt/gfp272.
   PubMed Web of Science ®Google Scholar
• Xiang, S.; Zhang, X.; Xie, X.; Wang, J.; Zhou, Q.; Chen, Z.; Wang, Y.; Liu, G.; Han, F.; Chen, J. High Serum Uric Acid Level is a Mortality Risk Factor in Peritoneal Dialysis Patients: A Retrospective Cohort Study. Nutr. Metab. (Lond). 2019, 16, 52. DOI: 10.1186/s12986-019-0379-y.
   PubMed Web of Science ®Google Scholar
• Richette, P.; Doherty, M.; Pascual, E.; Barskova, V.; Becce, F.; Castañeda-Sanabria, J.; Coyfish, M.; Guillo, S.; Jansen, T. L.; Janssens, H.; et al. 2016 Updated EULAR Evidence-Based Recommendations for the Management of Gout. Ann. Rheum. Dis. 2017, 76, 29–42. DOI: 10.1136/annrheumdis-2016-209707.
   PubMed Web of Science ®Google Scholar
• Sivera, F.; Andrés, M.; Carmona, L.; Kydd, A. S. R.; Moi, J.; Seth, R.; Sriranganathan, M.; van Durme, C.; van Echteld, I.; Vinik, O.; et al. Multinational Evidence-Based Recommendations for the Diagnosis and Management of Gout: Integrating Systematic Literature Review and Expert Opinion of a Broad Panel of Rheumatologists in the 3e Initiative. Ann. Rheum. Dis. 2014, 73, 328–335. DOI: 10.1136/annrheumdis-2013-203325.
   PubMed Web of Science ®Google Scholar
• FitzGerald, J. D.; Dalbeth, N.; Mikuls, T.; Brignardello-Petersen, R.; Guyatt, G.; Abeles, A. M.; Gelber, A. C.; Harrold, L. R.; Khanna, D.; King, C.; et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthrit. Care Res. 2020, 72, 744–760. DOI: 10.1002/acr.24180.
   PubMed Web of Science ®Google Scholar
• Bardin, T. Hyperuricemia Starts at 360 Micromoles (6 Mg/DL). Joint Bone Spine. 2015, 82, 141–143. DOI: 10.1016/j.jbspin.2015.01.002.
   PubMed Web of Science ®Google Scholar
• von Elm, E.; Altman, D. G.; Egger, M.; Pocock, S. J.; Gøtzsche, P. C.; Vandenbroucke, J. P., STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Bull. World Health Organ. 2007, 85, 867–872. DOI: 10.2471/blt.07.045120.
   PubMed Web of Science ®Google Scholar
• Arrieta, J.; Bajo, M. A.; Caravaca, F.; Coronel, F.; García-Pérez, H.; González-Parra, E.; Granado, A.; Martín-Govantes, J.; Miguel, A.; Molina, A.; et al. Guidelines of the Spanish Society of Nephrology. Clin. Pract. Guidelines Peritoneal Dial. 2006, 26, 1–184.
   Google Scholar
• Dombros, N.; Dratwa, M.; Feriani, M.; Gokal, R.; Heimbürger, O.; Krediet, R.; Plum, J.; Rodrigues, A.; Selgas, R.; Struijk, D.; Verger, C. EBPG Expert Group on Peritoneal Dialysis. European Best Practice Guidelines for Peritoneal Dialysis. 7 Adequacy of Peritoneal Dialysis. Nephrol. Dial. Transpl. 2005, 20, ix24–ix27. DOI: 10.1093/ndt/gfi1121.
   PubMed Web of Science ®Google Scholar
• Young, G. A.; Parsons, F. M. The Effect of Peritoneal Dialysis upon the Amino Acids and Other Nitrogenous Compounds in the Blood and Dialysates from Patients with Renal Failure. Clin. Sci. 1969, 37, 1–10.
   PubMed Web of Science ®Google Scholar
• Pascual, E.; Andrés, M.; Vázquez-Mellado, J.; Dalbeth, N. Severe Gout: Strategies and Innovations for Effective Management. Joint Bone Spine. 2017, 84, 541–546. DOI: 10.1016/j.jbspin.2016.10.004.
   PubMed Web of Science ®Google Scholar
• Arenas, M.-D.; Soriano, R.; Andrés, M.; Pascual, E. Serum Urate Levels of Hemodialyzed Renal Patients Revisited. J. Clin. Rheumatol. 2020. DOI: 10.1097/RHU.0000000000001438..
   PubMedGoogle Scholar
• Merchant, A. A.; Quinn, R. R.; Perl, J. Dialysis Modality and Survival: Does the Controversy Live on?Curr. Opin. Nephrol. Hypertens. 2015, 24, 276–283. DOI: 10.1097/MNH.0000000000000114.
   PubMed Web of Science ®Google Scholar
• Eloot, S.; Vanholder, R.; Dequidt, C.; Van Biesen, W. Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over Study. Perit. Dial. Int. 2015, 35, 436–442. DOI: 10.3747/pdi.2013.00202.
   PubMed Web of Science ®Google Scholar
• Otowa, T.; Sakurada, T.; Nagasawa, M.; Shimizu, S.; Yokoyama, T.; Kaneshiro, N.; Konno, Y.; Shibagaki, Y.; Kimura, K. Clinical Outcomes in Elderly (More than 80 Years of Age) Peritoneal Dialysis Patients: Five Years’ Experience at Two Centers. Adv. Perit. Dial. 2013, 29, 43–45.
   PubMedGoogle Scholar
• Ankli, B.; Berger, C. T.; Haeni, N.; Kyburz, D.; Hgle, T.; So, A. K.-L.; Daikeler, T. The Target Uric Acid Level in Multimorbid Patients with Gout is Difficult to Achieve: Data from a Longitudinal Swiss Single-Centre Cohort. Swiss. Med. Wkly. 2019, 149, w201221. DOI: 10.4414/smw.2019.20121..
   Web of Science ®Google Scholar